Nimble Partnerships in the Pharma Industry Well-Designed CRO Relationships Enhance Focus and Flexibility

ICON Clinical Research is a sponsor at 6th Annual BioPharma Asia Convention 2013. In her whitepaper ICON Clinical Research identifies four types of clinical research organization (CRO) relationships. A pharmaceutical company's CRO relationships should reflect its corporate strategy and its views on which clinical development capabilities can be outsourced and which should remain in-house managing partnerships with CROs. The four …

AbSolute® High Cap: Revolutionary Protein A Media

Group Novasep is a sponsor at 6th Annual BioPharma Asia Convention 2013. In the whitepaper Group Novasep outlines the real potential of AbSolute® High Cap for large scale processes and various biomolecule separations (mAbs and lgGs). Novasep invites you to discover our most recent white papers: one on the topic of TFF and the other on our protein A media, …

Key Figures and Top Rankings in the BioPharma Industry

According to EvaluatePharma, there is going to be some reshuffling of the top pharma rankings . It is estimated that in 2018, Novartis will be overtaking Pfizer as the top pharmaceutical company (ranked by prescription-drug revenue), with Sanofi coming in third position. Runner-ups include GlaxoSmithKline, Roche and Merck & Co. respectively. The top 6 pharmas are estimated to enjoy sales …

What you missed at Biopharma Asia Convention 2012

Biopharma Asia Convention 2012 was a resounding success. Over 2000 senior level attendees joined us in Singapore in March to meet, network, and discuss latest industry trends, partnership models and investment opportunities in Asia’s emerging biopharma industry. Across the four days of strategic content driven programme and intensive networking sessions, this event saw a total of: > Over 800 senior …

Driving productivity with an automated nanoliter scale #immunoassay platform – #download

Discover how to increase prodcutivity with an automated nanoliter scale immunoassay platform from Karolina Österlund, Manager Field Application Specialists, EU and Asia, Gyros AB, Sweden. Ms. Österlund brings her expertise in ligand binding assays to support development of biotherapeutics as well as implementation of Gyros technology to the Asia-Pacific region. She has been providing technical support for the Gyrolab immunoassay …

Utilising tools and strategies to manage mega clinical trials globally – #download

Find out more on about the utilising of tools and strategies to manage mega clinical trials from Andy Lawton, Head of Biometrics and Data Management, Boehringer Ingelheim, UK. Andy Lawton is currently the Head of Biometrics and Data Management, Boehringer Ingelheim, UK. He has a degree in Mathematics and Geology from Keele followed by Postgraduate work on Statistical Geophysics – …

Overcoming #bottlenecks during #recovery and #downstream processing – #download

Learn how to solve bottlenecks during reocvery and downstream proceessing from Dr. Jonas Anders, Director Marketing Chromatography, Affliate Merck Millipore Biopgarm Process Solutions, Merck KGaA, Germany. Dr. Jonas Anders has more than 15 years of experiencee in various R&D, marketing and management functions in the area of Life Sciences. He graduated as a chemical engineer at the Technical University in …

Uncovering opportunities for new drugs to treat #cardiometabolic diseases – #downloads

Discover new opportunities to treat cardiometabolic diseases from Dr. Rebecca Taub, Senior Vice President, VIA Pharmaceuticals, USA. Rebecca A. Taub, M.D. has served as Senior Vice President, Research and Development of VIA Pharmaceuticals sincee 2008. At VIA, she leads the efforts in Cardiometabolic drug discovery and development. From 2004-2008, she was Vicee President, Research, Metabolic Diseases at Hoffman-La Roche focusing …

Overcoming challenges of variable #biological production processes through Process Analytical Technologies (#PAT) – #downloads

Know more about the challenges of variable biological production processes through Proceess Analytical Technology (PAT), and how to overcome them, from Li – Hong Malmberg, Director, Technical Operations & Biologic Manufacturing, Abbott, USA. Li Joined Abbott in 1994, shortly after receiving her PhD in Chemical Engineering from the University of Minnesota. Since then, she held severnal postions with increasing responsibilities …